Schwarcz, Szandra
Kovács, Patrik
Nyerges, Petra
Ujlaki, Gyula
Sipos, Adrienn
Uray, Karen
Bai, Péter
Mikó, Edit http://orcid.org/0000-0001-7584-445X
Article History
Received: 6 September 2023
Revised: 8 May 2024
Accepted: 10 May 2024
First Online: 23 May 2024
Competing interests
: Péter Bai is a CEO and shareholder of Holobiont Diagnostics LTD, a developer of cancer diagnostic tests. Other authors declare no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.